Delving into the Latest Updates on Estetra SPRL with Synapse

A single center, randomized, open-label, controlled, three-arm study to evaluate the effect of a new combined oral contraceptive (COC) containing 15 mg Estetrol (E4) and 3 mg Drospirenone (DRSP) and of two reference COCs containing either 30 mcg Ethinylestradiol (EE) and 150 mcg Levonorgestrel (LNG) or 20 mcg EE and 3 mg DRSP on endocrine function, metabolic control and hemostasis during 6 treatment cycles - E4/DRSP endocrine function, metabolic control and hemostasis study

开始日期2016-09-05

申办/合作机构

Estetra SPRL

NL-OMON43025 / CompletedN/A

A randomized, double-blind, placebo-controlled, parallel, single center study to investigate the pharmacokinetics, safety, and tolerability of Estetrol (E4) in combination with Drospirenone (DSRP) after single and multiple dosing in healthy women. - E4/DRSP single and multiple dose PK and early QT study.

开始日期2016-04-14

申办/合作机构

Estetra SPRL

EUCTR2015-003150-40-CZ / Not yet recruiting临床3期

A Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15 mg Estetrol and 3 mg Drospirenone - E4 FREEDOM

开始日期2016-03-11

申办/合作机构

Estetra SPRL

100 项与 Estetra SPRL 相关的临床结果

登录后查看更多信息

0 项与 Estetra SPRL 相关的专利（医药）

登录后查看更多信息

100 项与 Estetra SPRL 相关的药物交易

登录后查看更多信息

100 项与 Estetra SPRL 相关的转化医学

登录后查看更多信息